The Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic across Europe
A new report, by Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation (AF), published…